Table 3.
Measurements (mean ± SD or percent) in patients who survived or died during the 30 days after starting C-SLED
| Alive (69) | Deceased (130) | P valuea | |
|---|---|---|---|
| Sex (male, %) | 65 | 69 | 0.43 |
| Age (years) | 58 ± 18 | 56 ± 15 | 0.20 |
| Weight (kg) | 88 ± 21 | 86 ± 22 | 0.47 |
| MAP (mmHg), pre–C-SLED | 76 ± 12 | 75 ± 13 | 0.19 |
| SOFA score, pre–C-SLED | 11.6 ± 4.1 | 14.2 ± 3.6 | 0.0001 |
| Serum albumin (g/l), pre–C-SLED | 2.47 ± 0.80 | 2.19 ± 0.70 | 0.043 |
| BUN (mg/dl), pre–C-SLED | 61 ± 30 | 64 ± 31 | 0.53 |
| Serum creatinine (mg/dl), pre–C-SLED | 3.9 ± 2.2 | 3.0 ± 1.3 | 0.006 |
BUN, blood urea nitrogen; C-SLED, continuous sustained low-efficiency dialysis; MAP, mean arterial pressure; SOFA, sequential organ failure assessment.
a
Comparison between alive and deceased groups.